• New Method of Diagnosing and Monitoring Gaucher Disease Uses Dried Blood Samples
  • #NORDsummit – Despite Criticism, Orphan Drug Act Is Working to Advance Needed Treatments, FDA Says
  • Parkinson’s Disease Risk Should Be Discussed Before Gaucher Genetic Testing, Patients Say
  • Neuropathic Gaucher Disease Mutations Speed Cognitive Decline in Parkinson’s, Study Finds
  • Researchers Suggest Lyso-Gb1 as Gaucher Treatment Response Marker
  • High Levels of Iron During Therapy Linked to Residual Gaucher Disease, Study Finds
  • Gaucher Disease Guidance Could Help Non-specialists Diagnosis It Better, Study Reports
  • Nerve Cell Damage Causes Pain in Gaucher Disease Type 1 Patients, Italian Study Suggests
  • Three Newly Identify Compounds Show Promise for Types 2 and 3 Gaucher Disease
  • Accordant’s Gaucher Program Receives NCQA Disease Management Accreditation
  • Cerdelga Trial Extension Confirms Improvements in Gaucher Type 1 Patients
  • Gaucher Patients Have Mixed Views About Substrate Reduction Therapies, Study Finds